Determinants of HIV-1 broadly neutralizing antibody induction. (Q40476608)

20 September 2017

Determinants of HIV-1 broadly neutralizing antibody induction. (English)

1 reference

20 September 2017

0 references

29

1 reference

20 September 2017

Christian W Thorball

14

0 references

Carsten Magnus

Carsten Magnus

10

0 references

Michael Huber

Michael Huber

6

0 references

Herbert Kuster

Herbert Kuster

15

0 references

Roger Kouyos

Roger D Kouyos

2

0 references

Jacques Fellay

Jacques Fellay

26

0 references

Huldrych F Günthard

Huldrych F Günthard

28

0 references

Matthias Cavassini

Matthias Cavassini

16

0 references

Claus Kadelka

Claus Kadelka

3

0 references

Manuel Battegay

20

Manuel Battegay

1 reference

20 September 2017

Swiss HIV Cohort Study

30

Swiss HIV Cohort Study

1 reference

20 September 2017

25

Jürg Böni

1 reference

20 September 2017

24

Thomas Klimkait

1 reference

20 September 2017

22

Sabine Yerly

1 reference

20 September 2017

19

Alexandra Calmy

1 reference

20 September 2017

17

Enos Bernasconi

1 reference

20 September 2017

Dominique Laurent Braun

Dominique L Braun

7

0 references

Andri Rauch

Andri Rauch

21

1 reference

ORCID Public Data File 2021

author name string

Peter Rusert

1

1 reference

20 September 2017

Hanna Ebner

4

1 reference

20 September 2017

Merle Schanz

5

1 reference

20 September 2017

Nathanael Hozé

8

1 reference

20 September 2017

Alexandra Scherrer

9

1 reference

20 September 2017

Jacqueline Weber

11

1 reference

20 September 2017

Therese Uhr

12

1 reference

20 September 2017

Valentina Cippa

13

1 reference

20 September 2017

Matthias Hoffmann

18

1 reference

20 September 2017

Vincent Aubert

23

1 reference

20 September 2017

Roland R Regoes

27

1 reference

20 September 2017

language of work or name

English

0 references

publication date

26 September 2016

1 reference

20 September 2017

1 reference

20 September 2017

22

1 reference

20 September 2017

1260-1267

1 reference

20 September 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.4187

20 September 2017

0 references

cites work

Antibody responses to envelope glycoproteins in HIV-1 infection

1 reference

Antibodies in HIV-1 vaccine development and therapy

21 January 2018

1 reference

HIV-1 neutralizing antibodies: understanding nature's pathways

21 January 2018

1 reference

Virological features associated with the development of broadly neutralizing antibodies to HIV-1

21 January 2018

1 reference

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

21 January 2018

1 reference

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

21 January 2018

1 reference

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

21 January 2018

1 reference

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

21 January 2018

1 reference

Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity

21 January 2018

1 reference

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm

21 January 2018

1 reference

A Blueprint for HIV Vaccine Discovery

21 January 2018

1 reference

The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection

21 January 2018

1 reference

Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort

21 January 2018

1 reference

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

21 January 2018

1 reference

Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies

21 January 2018

1 reference

Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables

21 January 2018

1 reference

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies

21 January 2018

1 reference

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

21 January 2018

1 reference

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

21 January 2018

1 reference

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

21 January 2018

1 reference

Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

21 January 2018

1 reference

The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection

21 January 2018

1 reference

Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising

21 January 2018

1 reference

Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression

21 January 2018

1 reference

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

21 January 2018

1 reference

Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses

21 January 2018

1 reference

Cohort profile: the Swiss HIV Cohort study.

21 January 2018

1 reference

Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection

21 January 2018

1 reference

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

Deliberate removal of T cell help improves virus-neutralizing antibody production.

21 January 2018

1 reference

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies

21 January 2018

1 reference

Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection

21 January 2018

1 reference

Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland

21 January 2018

1 reference

The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland

21 January 2018

1 reference

Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines

21 January 2018

1 reference

Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains

21 January 2018

1 reference

Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization

21 January 2018

1 reference

Early development of broadly neutralizing antibodies in HIV-1-infected infants

21 January 2018

1 reference

Insights into the trimeric HIV-1 envelope glycoprotein structure

21 January 2018

1 reference

Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.

21 January 2018

1 reference

HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men.

21 January 2018

1 reference

Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED.

21 January 2018

1 reference

Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys

21 January 2018

1 reference

A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort

21 January 2018

1 reference

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

CATNAP: a tool to compile, analyze and tally neutralizing antibody panels

21 January 2018

1 reference

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies

21 January 2018

1 reference

A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals

21 January 2018

1 reference

Characteristics of the earliest cross-neutralizing antibody response to HIV-1.

21 January 2018

1 reference

Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.

21 January 2018

1 reference

Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors

21 January 2018

1 reference

Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies

21 January 2018

1 reference

Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection

21 January 2018

1 reference

Objective Criteria for the Evaluation of Clustering Methods

21 January 2018

1 reference

Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27668936

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27668936

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27668936

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.4187

1 reference

20 September 2017

1 reference